Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Dotor

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Cell and Tissue Research|January 6, 2015
Co-migration of colon cancer cells and CAFs induced by TGFβ₁ enhances liver metastasisIdoia Gonzalez-Zubeldia, Javier Dotor, Miriam Redrado, et al.
Cancer Research|April 3, 2008
A novel lung cancer signature mediates metastatic bone colonization by a dual mechanismSilvestre Vicent, Diego Luis-Ravelo, Iker Antón, et al.
The Journal of Investigative Dermatology|August 25, 2005
Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosisBegoña Santiago, Irene Gutierrez-Cañas, Javier Dotor, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2014
Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cellsDaniel R Neill, William R Coward, Jenna F Gritzfeld, et al.
Cancer Research|December 17, 2010
Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppressionNancy Díaz-Valdés, María Basagoiti, Javier Dotor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacementsEduardo Huarte, Pablo Sarobe, Jun Lu, et al.
Biochemical Pharmacology|December 2, 2008
TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesisSimona Serratì, Francesca Margheri, Marco Pucci, et al.
Investigative Ophthalmology & Visual Science|August 4, 2011
Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptidesSergio Recalde, Javier Zarranz-Ventura, Patricia Fernández-Robredo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccinationNoelia Casares, Laura Arribillaga, Pablo Sarobe, et al.
Cytokine|December 28, 2010
Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosisLaura Arribillaga, Javier Dotor, María Basagoiti, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cell and Tissue Research|January 6, 2015
Co-migration of colon cancer cells and CAFs induced by TGFβ₁ enhances liver metastasisIdoia Gonzalez-Zubeldia, Javier Dotor, Miriam Redrado, et al.
Cancer Research|April 3, 2008
A novel lung cancer signature mediates metastatic bone colonization by a dual mechanismSilvestre Vicent, Diego Luis-Ravelo, Iker Antón, et al.
The Journal of Investigative Dermatology|August 25, 2005
Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosisBegoña Santiago, Irene Gutierrez-Cañas, Javier Dotor, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2014
Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cellsDaniel R Neill, William R Coward, Jenna F Gritzfeld, et al.
Cancer Research|December 17, 2010
Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppressionNancy Díaz-Valdés, María Basagoiti, Javier Dotor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacementsEduardo Huarte, Pablo Sarobe, Jun Lu, et al.
Biochemical Pharmacology|December 2, 2008
TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesisSimona Serratì, Francesca Margheri, Marco Pucci, et al.
Investigative Ophthalmology & Visual Science|August 4, 2011
Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptidesSergio Recalde, Javier Zarranz-Ventura, Patricia Fernández-Robredo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccinationNoelia Casares, Laura Arribillaga, Pablo Sarobe, et al.
Cytokine|December 28, 2010
Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosisLaura Arribillaga, Javier Dotor, María Basagoiti, et al.
Pageof 5